Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $225.98 million. The enterprise value is $135.55 million.

Market Cap	225.98M
Enterprise Value	135.55M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, before market open.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

LXEO has 54.85 million shares outstanding. The number of shares has increased by 176.82% in one year.

Current Share Class	54.85M
Shares Outstanding	54.85M
Shares Change (YoY)	+176.82%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	2.74%
Owned by Institutions (%)	56.09%
Float	42.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.57
P/TBV Ratio	2.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.42, with a Debt / Equity ratio of 0.11.

Current Ratio	3.42
Quick Ratio	3.24
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-908.44

Financial Efficiency

Return on equity (ROE) is -80.65% and return on invested capital (ROIC) is -49.83%.

Return on Equity (ROE)	-80.65%
Return on Assets (ROA)	-42.89%
Return on Invested Capital (ROIC)	-49.83%
Return on Capital Employed (ROCE)	-122.57%
Revenue Per Employee	n/a
Profits Per Employee	-$1.52M
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.86%
50-Day Moving Average	3.48
200-Day Moving Average	5.57
Relative Strength Index (RSI)	57.55
Average Volume (20 Days)	683,515

Short Selling Information

The latest short interest is 4.78 million, so 8.72% of the outstanding shares have been sold short.

Short Interest	4.78M
Short Previous Month	3.78M
Short % of Shares Out	8.72%
Short % of Float	11.18%
Short Ratio (days to cover)	5.92

Income Statement

Revenue	n/a
Gross Profit	-75.52M
Operating Income	-116.28M
Pretax Income	-69.42M
Net Income	-109.31M
EBITDA	-115.67M
EBIT	-116.28M
Earnings Per Share (EPS)	-$3.31

Full Income Statement

Balance Sheet

The company has $99.83 million in cash and $9.40 million in debt, giving a net cash position of $90.43 million or $1.65 per share.

Cash & Cash Equivalents	99.83M
Total Debt	9.40M
Net Cash	90.43M
Net Cash Per Share	$1.65
Equity (Book Value)	88.12M
Book Value Per Share	2.66
Working Capital	74.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.00 million and capital expenditures -$296,000, giving a free cash flow of -$88.30 million.

Operating Cash Flow	-88.00M
Capital Expenditures	-296,000
Free Cash Flow	-88.30M
FCF Per Share	-$1.61

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-176.82%
Shareholder Yield	-176.82%
Earnings Yield	-48.37%
FCF Yield	-39.07%

Analyst Forecast

The average price target for LXEO is $16.60, which is 302.91% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.60
Price Target Difference	302.91%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	1.39%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1